Bio-Solutions Continues Pursuit of $25 Billion Diabetes Marketplace (BISU)

The stock of Bio-Solutions (OTC: BISU) staged a solid rally today as the company updated shareholders on its progress of entering the $25 billion diabetes marketplace. Bio-Solutions rose 7.7%, closing at a share price of $0.021. With 1.11 million shares exchanging hands compared to its daily average of 81,710, the stock also traded at a high volume today.

Bio-Solutions now has a total gain of 114.3% since the start of 2012. The stock had a huge breakout on January 31, 2012, trading to an annual high of $0.059 per share. The stock declined since that point and experienced a few mini-breakouts in recent months.

Since the acquisition Type2 Defense in September 2011, Bio-Solutions has engaged in running a test trail of the T2 product in an American suburban community. The purpose of this test trail is to gauge the response and feedback from a segment of the population towards the Type2 Defense product.

Type2 Defense is a glucose-control dietary supplement powder formulated to help support healthy glucose levels, in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to support healthy glucose levels for Type II Diabetics and Pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

On July 30, 2012, Bio-Solutions announced that the company had started production of the recently acquired Type2 Defense, pursuing the $25 billion type II and pre-diabetic marketplace.

There are 11 promotions listed on for Bio Solutions. Stock Plays Online promoted Bio-Solutions today, and was compensated $2000 from a non-affiliate third party. On Twitter, @pennystock24 mentioned that Investor Chat Room also promoted Bio Solutions today.

Other notable recent headlines for Bio-Solutions include:

  • Yesterday, August 7, 2012: Bio-Solutions announced the addition of Ms. Dana Kraft as a team member.
  • June 19, 2012: As Bio-Solutions launched Type2 Defense, a state-of-the-art functional beverage for the management of Type 2 diabetes, President and CEO Bill Gallagher announced that the company moved the corporate headquarters from Montreal, Canada to San Antonio, Texas, which placed Bio-Solutions at the geographic hub of cutting-edge research in the fight against diabetes.

Incorporated on March 27, 2007, Bio-Solutions is a development stage company. The company’s supplier for the raw material used in its Nutra-Animal blend is called Oceanutrasciences, also known as Aqua-Biokem. Its primary market is chicken integrators, as well as chicken feed manufacturers in Canada.

Please make sure to read and completely understand our disclaimer at While reading this article one must assume that we may be compensated for posting this content on our website.

Published by Fiona Gibson

Fiona is a finance graduate and an expert in analyzing market trends.

Recent Stories

SignUp Now For Our Featured Newsletter